image

SEC Filings

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
Filing date Description Form View

Report of unscheduled material events or corporate event

8-K EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML

Annual report which provides a comprehensive overview of the company for the past year

10-K EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML

Securities offered to employees pursuant to employee benefit plans

S-8 View HTML

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

424B5 View HTML

Report of unscheduled material events or corporate event

8-K EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Report of unscheduled material events or corporate event

8-K EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

An amendment to the SC 13G filing

SC 13G/A View HTML

Data provided by Kaleidoscope.